aminocaproic acid has been researched along with Sclerosis, Systemic in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| REQUE, PG | 1 |
1 other study available for aminocaproic acid and Sclerosis, Systemic
| Article | Year |
|---|---|
THE TREATMENT OF SYSTEMIC SCLEROSIS: WITH SPECIAL REFERENCE TO EPSILON AMINOCAPROIC ACID.
Topics: Aminocaproates; Aminocaproic Acid; Drug Therapy; Humans; Physical Therapy Modalities; Psychology; Sc | 1965 |